Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riichiro Abe

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
The Journal of Dermatology|October 31, 2014
Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysisRiichiro Abe
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|June 2, 2011
[Therapy for skin disease using bone marrow cells]Riichiro Abe
Journal of Dermatological Science|July 29, 2008
Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseasesRiichiro Abe
The Journal of Investigative Dermatology|March 17, 2007
Soluble Fas ligand: is it a critical mediator of toxic epidermal necrolysis and Stevens-Johnson syndrome?Junko Murata, Riichiro Abe
Current Opinion in Allergy and Clinical Immunology|June 12, 2025
Immune phenotyping impacts on management of severe cutaneous adverse reactionRyota Hayashi, Riichiro Abe
Chinese Medical Journal|September 6, 2024
Stevens-Johnson syndrome and toxic epidermal necrolysis: Updates in pathophysiology and managementAkito Hasegawa, Riichiro Abe
Brain and Nerve = Shinkei Kenkyu No Shinpo|April 17, 2019
[Cutaneous Adverse Drug Reaction Caused by Antiepileptic Drug]Tokiko Deguchi, Riichiro Abe
F1000Research|June 30, 2020
Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysisAkito Hasegawa, Riichiro Abe
Current Opinion in Allergy and Clinical Immunology|June 7, 2023
New insights into the diagnosis and management of Stevens-Johnson syndrome and toxic epidermal necrolysisYuki Saito, Riichiro Abe
Current Pharmaceutical Design|May 14, 2008
AGE-RAGE system and carcinogenesisRiichiro Abe, Sho-ichi Yamagishi
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
The Journal of Dermatology|October 31, 2014
Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysisRiichiro Abe
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|June 2, 2011
[Therapy for skin disease using bone marrow cells]Riichiro Abe
Journal of Dermatological Science|July 29, 2008
Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseasesRiichiro Abe
The Journal of Investigative Dermatology|March 17, 2007
Soluble Fas ligand: is it a critical mediator of toxic epidermal necrolysis and Stevens-Johnson syndrome?Junko Murata, Riichiro Abe
Current Opinion in Allergy and Clinical Immunology|June 12, 2025
Immune phenotyping impacts on management of severe cutaneous adverse reactionRyota Hayashi, Riichiro Abe
Chinese Medical Journal|September 6, 2024
Stevens-Johnson syndrome and toxic epidermal necrolysis: Updates in pathophysiology and managementAkito Hasegawa, Riichiro Abe
Brain and Nerve = Shinkei Kenkyu No Shinpo|April 17, 2019
[Cutaneous Adverse Drug Reaction Caused by Antiepileptic Drug]Tokiko Deguchi, Riichiro Abe
F1000Research|June 30, 2020
Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysisAkito Hasegawa, Riichiro Abe
Current Opinion in Allergy and Clinical Immunology|June 7, 2023
New insights into the diagnosis and management of Stevens-Johnson syndrome and toxic epidermal necrolysisYuki Saito, Riichiro Abe
Current Pharmaceutical Design|May 14, 2008
AGE-RAGE system and carcinogenesisRiichiro Abe, Sho-ichi Yamagishi
Pageof 14